Tag Archives: michael Schöll

Inaugural UCL “Biomarkers for neurodegenerative diseases” PhD course in London highly appreciated

The second edition of a PhD course on Biomarkers for neurodegenerative diseases took place on 2-5 April at UCL in London as a collaboration with the University of Gothenburg, where it was established in 2018.  The course featured lectures and interactive group assignments on a range of topics covering biomarkers in blood and cerebrospinal fluid, as well…
Read more

Nya medel till forskning om neurodegenerativa sjukdomar

Michael Schölls forskargrupp beviljades nyligen totalt 2 Mkr i ALF-medel till projektet ”Translationell studie för att identifiera de tidiga patogena processerna som leder till neurodegenerativa sjukdomar”. Schöll är forskare vid Göteborgs universitet, Wallenberg Centre for Molecular and Translational Medicine och MedTech West. Från The Association for Frontotemporal Degeneration (AFTD) har Michael Schöll tillsammans med forskarkolleger vid…
Read more

New PET tau tracer outperforms established MRI measures

Michael Schöll Michael Schöll, Associate Professor at the Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg and MedTech West, is co-author of the article “Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders“, published in JAMA in September, 2018. To diagnose Alzheimer’s disease reliably is still…
Read more

The 2nd Biomarkers in Neurodegenerative Diseases course- next time in London

In April 2018 the inaugural Biomarkers in neurodegenerative diseases course took place at the University of Gothenburg, and now the 2nd Biomarkers in Neurodegenerative Diseases course will be held in April 2019 in Queen Square, London, as an exciting UCL/University of Gothenburg collaboration. Aimed at PhD level and beyond, this detailed and comprehensive 4 day…
Read more